PATENT CLAIM ANALYSIS

Application Number: 16028730
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "235200"]

Abstract:
The invention provides methods of treatment of a progressive bone disease, such as osteoporosis, Paget's Disease, multiple myeloma, or hyperparathyroidism, comprising administration of an effective amount of a non-agonist PPARG modulator to a patient afflicted with the disease.

Claim (Index 9):
The method of  claim 1 , wherein R 4  is \u2014CO 2 H, \u2014(CH 2 ) m CO 2 H, \u2014O(CH 2 ) m CO 2 H, \u2014CN, \u2014(CH 2 ) m CN, \u2014O(CH 2 ) m CN, \u2014C(CH 3 ) 2 CO 2 H, \u2014C(CH 3 ) 2 CN, \u2014OC(CH 3 ) 2 CO 2 H, \u2014OC(CH 3 ) 2 CN, \u2014CH(CH 3 )CO 2 H, \u2014CH(CH 3 )CN, \u2014OCH(CH 3 )CO 2 H, \u2014OCH(CH 3 )CN; \u2014CH(CH 2 CH 3 )CO 2 H, \u2014CH(CH 2 CH 3 )CN, \u2014OCH(CH 2 CH 3 )CO 2 H, \u2014OCH(CH 2 CH 3 )CN; \u2014CH(i-Pr)CO 2 H, \u2014CH(i-Pr)CN, \u2014OCH(i-Pr)CO 2 H, \u2014OCH(i-Pr)CN, wherein iPr indicates isopropyl; \u2014CH(t-Bu)CO 2 H, \u2014CH(t-Bu)CN, \u2014OCH(t-Bu)CO 2 H, \u2014OCH(t-Bu)CN, wherein t-Bu indicates t-butyl; \u2014(CHR\u2033) m C(\u2550O)N(R\u2033) 2 , \u2014O(CHR\u2033) m C(\u2550O)N(R\u2033) 2 , wherein a wavy line indicates a point of attachment.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15302862', '13490324', '13490342', '13811965', '14060563']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7475403779830585
- 35 USC 102 Novelty (BERT): 0.6148362401894067
- Combined Prediction Score: 0.7342699642036934
- Mean Citation Score: 348.215824
- Max Citation Score: 526.92584
- Similarity Product: 505.31166868841655

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test